WKN DE: A40SSV / ISIN: CNE100002W43

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Zhejiang Shengda Bio-Pharm a Times and Sales (SHA)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Zhejiang Shengda Bio-Pharm Co., Ltd. Registered Shs -A-

Weitere Meldungen

04:12		Japan’s Nikkei rises past 72,000 mark for first time as AI euphoria persists
04:05		Most Investors Have Never Heard of This Nuclear Stock Related to SpaceX. That's About to Change.
04:02		Bitcoin, Ethereum, XRP, Dogecoin Flat Amid Trump's Threat On Hormuz Strait To Iran: Analyst Says BTC Breaking This Level Will 'Trigger' Bull Market
04:00		1 Mind-Boggling Metric That Makes Nvidia Stock a Screaming Buy
03:15		Could Pfizer Stock Be Your Ticket to Generational Wealth?
03:02		Singapore dollar set to gain despite hawkish US Fed: analysts
03:00		China AI rally broadens as funds move past overvalued first-tier winners to indirect beneficiaries
02:46		It’s SpaceX IPO Day!
02:34		Shipping slows after Iran says it has again shut the Strait of Hormuz
02:15		Deniz Undav: Germany's 2026 World Cup supersub
02:15		3 Lessons From the SpaceX IPO Every Investor Should Know Before Anthropic and OpenAI Hit the Market
01:10		Fake romance to missed deliveries: How to protect yourself from three common scams
01:00		Info-Tech Systems wants to leverage customers’ overseas expansion for future growth
01:00		Healthcare is sector least affected by geopolitical tensions, say CBC Group and GHO Capital after US$21 billion merger
01:00		S&P 500 holds on to bullish momentum amid increasing volatility
01:00		Middle East conflict pushes Asia into next phase of energy rethink: Bank of America
01:00		US startup Databricks to raise Singapore headcount by up to 50% as AI demand grows
01:00		Great Eastern goes on the high-net-worth offensive, but don’t call it a pivot
01:00		You Can't Buy Anthropic Stock Yet, but You Can Buy These 4 AI Stocks Instead
00:10		CoreWeave is Joining the Nasdaq-100. Is the Stock a Buy?
00:05		A Blood Test That Screens for 50+ Cancers Just Moved Closer to Real-World Use. Here's What It Means for Grail Investors.
00:03		Czechia: Thousands march in support of public media funding
21.06.26		Investors Flee Cathie Wood's ARKK ETF As It Trails S&P 500, Nasdaq 100 By Far
21.06.26		SpaceX Shares Soared After Their First Day of Trading, Post-IPO. Will the Stock Keep Rising?
21.06.26		Nio Stock Falls to Key Support Level Despite Strong Delivery and Revenue Growth
21.06.26		Top Three Reasons Why Tom Lee’s BMNR Stock May Be on the Cusp of a Deeper Dive
21.06.26		Rocket Lab Stock Has Dived After SpaceX IPO, But Top Analysts Predict A Rebound
21.06.26		Is Now a Good Time to Buy Tilray Brands Stock?
21.06.26		A Lindblad Expeditions Director Sold Nearly 53,000 Shares Worth $1.2 Million. Here's a Deeper Look at the Transaction.
21.06.26		Today's Wordle Hints, Answer and Help for June 22, #1829
21.06.26		The Entire Micron Investment Thesis Comes Down to This One Number
21.06.26		Tesla Driver Using Autopilot Crashes Into Home in Texas and Kills a Woman, Officials Say
21.06.26		Bloom Energy Soared After a New AI Power Report. Is the Fuel Cell Stock a Buy?
21.06.26		2 Reasons to Wait Before Buying SpaceX Shares, and 1 Reason to Buy Right Now
21.06.26		Obama National Security Adviser Blasts Trump’s Iran Deal As Strategic Blunder, Calls It Egregious: ‘In The Obama-Era Deal, They Could Only…’
21.06.26		Building materials group CRH nears its biggest-ever deal to buy Arcosa
21.06.26		Think a Roth IRA Is Your Best Bet for Retirement Savings? Here's Why It Could Backfire.
21.06.26		Lindsey Graham Warns Iran Deal Could Fail Amid Trump’s Latest Strike Warning: ‘When You Use Hezbollah To Attack Israel…’
21.06.26		DRAM ETF Assets Hit $21 Billion AUM, But Key Risks May Lead To A Reversal
21.06.26		NVIDIA Stock Has Slipped By 10% From YTD High As Pros Predict 46% Jump
21.06.26		Intel Is Stealing the Foundry Spotlight. Is TSMC Still the Most Important Company in Chips?
21.06.26		Elizabeth Warren Targets Elon Musk In Renewed Push For Ultra-Millionaire Tax
21.06.26		Wars trigger $12bn venture capital rush into defence tech
21.06.26		Top 10: Der beste Saugroboter mit Wischfunktion im Test - Testsieger Roborock
21.06.26		1 Reason Why the Fed's Decision to Keep Interest Rates Steady Is No Match for Costco Stock
21.06.26		Top Three Catalysts For Dow, Nasdaq 100, and S&P 500 This Week
21.06.26		SpaceX Just Had the Biggest IPO in History. Here's What It Tells Investors About Buying Anthropic and OpenAI When They Go Public.
21.06.26		Down 10% From Its Peak, Is Amazon Stock the Ultimate Summer Buying Opportunity?
21.06.26		‘Toy Story 5’ Fuels Hollywood’s Hottest Summer Since 2019
21.06.26		Is Alphabet the Best "Magnificent Seven" AI Stock?

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Zhejiang Three Stars New Materials Zhejiang Chengbang Landscape Shanghai Tianyang Hot Melt Adhesives Hefei Changqing Machinery ZHEJIANG TIELIU CLUTCH

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	22.06.2026 05:08
Kaufwert:	EUR
	Hinzufügen Speichern

Zhejiang Shengda Bio-Pharm a Aktie

WKN DE: A40SSV / ISIN: CNE100002W43

Zhejiang Shengda Bio-Pharm a Times and Sales (SHA)

Times and Sales

Analysen zu Zhejiang Shengda Bio-Pharm Co., Ltd. Registered Shs -A-

Weitere Meldungen